| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.5 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |